Apoptosis
Autonomous University Publishes Research in Apoptosis
Published in Cancer Weekly, April 3rd, 2012
2012 APR 3 -- New investigation results, "Targeting the Fas/FasL signaling pathway in cancer therapy," are detailed in a study published in Expert Opinion On Therapeutic Targets. According to the authors of a study from Madrid, Spain, "The Fas/FasL system plays a significant role in tumorigenesis. Research has shown that its impairment in cancer cells may lead to apoptosis resistance and contribute to tumor progression."
"Thus, the development of effective therapies targeting the Fas/FasL system may play an important role in the fight against cancer. AREAS COVERED: In this review the recent literature on targeting the Fas/FasL system for therapeutic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2012-04-03)
More Articles from Cancer Weekly
- Prostate Cancer
Academic Urology Prostate Center Receives ACR Accreditation - Antioxidants
Brigham and Women's Hospital and Harvard University School of Medicine Describes Research in Antioxidants - Colorectal Research
CDC and AGA Join Forces to Bring Colorectal Cancer Screening to the Uninsured - Lung Cancer
CYFRA21-1 might be predictive marker in advanced NSCLC - Gastric Cancer
Cancer Hospital Reports Research in Gastric Cancer - Cancer Technology
Data on Cancer Technology Published by Researchers at General Hospital - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
